Partial improvement of solar urticaria after omalizumab
Authors:
- Kirk H. WaibelKWKirk H. Waibel
- Drew A. ReeseDRDrew A. Reese
- Robert G. HamiltonRHRobert G. Hamilton
- Richard L. DevillezRDRichard L. Devillez
- 1 February 2010
- journal article
- other
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 125 (2) , 490-491
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- A case of severe refractory chronic urticaria: A novel method for evaluation and treatmentAllergy and Asthma Proceedings, 2009
- Therapeutic efficacy of omalizumabJournal of Allergy and Clinical Immunology, 2009
- Solar urticariaJournal of the American Academy of Dermatology, 2008
- Successful treatment of solar urticaria with anti‐immunoglobulin E therapyAllergy, 2008
- Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgEJournal of Allergy and Clinical Immunology, 2006
- Accuracy of US Food and Drug Administration–cleared IgE antibody assays in the presence of anti-IgE (omalizumab)Journal of Allergy and Clinical Immunology, 2006
- Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving Omalizumab (Xolair) therapyJournal of Immunological Methods, 2005
- Solar Urticaria: A Report on 57 CasesDermatitis®, 2000
- Pathogenesis and classification of solar urticaria: A new conceptJournal of the American Academy of Dermatology, 1989
- Immunologic and Biophysical Studies in Solar UrticariaJournal of Investigative Dermatology, 1963